Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To compare abnormalities determined in 2-deoxy-2-[18F]fluoro-D-glucose (FDG) and [11C]flumazenil (FMZ) PET images with intracranial EEG data in patients with extratemporal lobe epilepsy. BACKGROUND: Although PET studies with FDG and FMZ are being used clinically to localize epileptogenic regions in patients with refractory epilepsy, the electrophysiologic significance of the identified PET abnormalities remains poorly understood. METHODS: We studied 10 patients, mostly children (4 boys, 6 girls, aged 2 to 19 years; mean age, 11 years), who underwent FDG and FMZ PET scans, intracranial EEG monitoring, and cortical resection for intractable epilepsy. EEG electrode positions relative to the brain surface were determined from MRI image volumes. Cortical areas of abnormal glucose metabolism or FMZ binding were determined objectively based on asymmetry measures derived from homotopic cortical areas at three asymmetry thresholds. PET data were then coregistered with the MRI and overlaid on the MRI surface. A receiver operating characteristics (ROC) analysis was performed to determine the specificity and sensitivity of PET-defined abnormalities against the gold standard of intracranial EEG data. RESULTS: FMZ PET detected at least part of the seizure onset zone in all subjects, whereas FDG PET failed to detect the seizure onset region in two of 10 patients. The area under the ROC curves was higher for FMZ than FDG PET for both seizure onset (p = 0.01) and frequent interictal spiking (p = 0.04). Both FMZ and FDG PET showed poor performance for detection of rapid seizure spread (area under the ROC curve not significantly different from 0.5). CONCLUSIONS: [11C]flumazenil (FMZ) PET is significantly more sensitive than 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET for the detection of cortical regions of seizure onset and frequent spiking in patients with extratemporal lobe epilepsy, whereas both FDG and FMZ PET show low sensitivity in the detection of cortical areas of rapid seizure spread. The application of PET, in particular FMZ PET, in guiding subdural electrode placement in refractory extratemporal lobe epilepsy will enhance coverage of the epileptogenic zone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Guerrini, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68182-8 · Cited by 848
Extracellular metabolites in the cortex and hippocampus of epileptic patients
Cavus, I., Kasoff, W. S., Cassaday, M. P., Jacob, R., Gueorguieva, R., Sherwin, R. S., Krystal, J. H., Spencer, D. D., & Abi‐Saab, W. M. (2005) · Annals of Neurology · doi:10.1002/ana.20380 · Cited by 292
PET and SPECT in epilepsy: a critical review.
la Fougère, C., Rominger, A., Förster, S., Geisler, J., & Bartenstein, P. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.02.025 · Cited by 224
“Moreover, [(11)C]flumazenil PET was shown to be more accurate than [(18)F]FDG-PET for the detection of cortical regions of seizure onset and frequent spiking in patients with extra-TLE, whereas both [(18)F]FDG and [(11)C]flumazenil PET showed low sensitivity in the detection of cortical areas of rapid seizure spread […”
Method
Metadata
- Authors
- Muzik, O., da Silva, E. A., Juhasz, C., Chugani, D. C., Shah, J., Nagy, F., Canady, A., von Stockhausen, H.-M., Herholz, K., Gates, J., Frost, M., Ritter, F., Watson, C., & Chugani, H. T.
- Venue
- Neurology
- Published
- 2000-01-11
- Volume
- 54
- Issue
- 1
- Pages
- 171-171
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2116146879
- Cited by
- 127
- References
- 0
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. https://app.cochat.ai/papers/10.1212/wnl.54.1.171
- The paper
- Muzik, O., da Silva, E. A., Juhasz, C., Chugani, D. C., Shah, J., Nagy, F., Canady, A., von Stockhausen, H.-M., Herholz, K., Gates, J., Frost, M., Ritter, F., Watson, C., & Chugani, H. T. (2000). Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology. https://doi.org/10.1212/wnl.54.1.171
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.